Literature DB >> 1879875

C3- and T-cell-dependent adjuvant activity of in vivo formed immune complexes.

C W Van den Berg1, M A Hazenberg, F M Hofhuis, S M Van Rooyen, H Van Dijk.   

Abstract

The effects of polyclonal antibodies to mouse serum components on the primary humoral immune response of mice in vivo were studied. It was observed that rabbit IgG to complement component C3 and albumin and mouse IgG to C5, but also heat-aggregated non-immune rabbit IgG, enhanced the agglutinating antibody response to sheep erythrocytes (SRBC). Since the increase in response was only observed when antigen and antibodies were administered via the same route (i.p.), immunological adjuvant activity was implicated. Ineffectiveness of anti-C5 IgG in C5-deficient mice indicated that the antibody-induced adjuvant activity is mediated by in vivo formed immune complexes (IC). The adjuvant activity of IC was reduced by selective C3-depletion of animals, pointing to a requirement of C3. The effect of variations in other parameters was studied with anti-C3 and anti-C5 IgG as immunoadjuvant. The immunostimulatory effect was most pronounced when the antibodies were administered simultaneously with or shortly before antigen. Treatment of animals with antibodies one or two days before antigen, however, resulted in a suppression of the response. The response to thymus-independent antigens was not enhanced by anti-C3 nor by anti-C5 IgG. Optimal adjuvant activity of anti-C3 IgG was observed at low antigen doses. Nude mice were insensitive to the immunopotentiating effect of anti-C3 and so was the F1 progeny of BALB/c male and CBA/N female mice expressing a B-cell maturation defect. C5 deficiency and lipopolysaccharide (LPS) non-responsiveness did not affect the adjuvant activity of in vivo formed C3-anti-C3 IC.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1879875      PMCID: PMC1384540     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  39 in total

1.  Functional assay of C5-activating and nonactivating cobra venom factor preparations in the mouse system.

Authors:  C W Van den Berg; P C Aerts; H Van Dijk
Journal:  J Immunol Methods       Date:  1990-10-19       Impact factor: 2.303

Review 2.  The immune complex: possible ways of regulating the antibody response.

Authors:  B Heyman
Journal:  Immunol Today       Date:  1990-09

3.  C5 does not play a major role in the immune response of mice to SRBC in vivo.

Authors:  C W van den Berg; P J van Horssen; F M Hofhuis; P C Aerts; H van Dijk
Journal:  Scand J Immunol       Date:  1991-05       Impact factor: 3.487

4.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

5.  Binding of C3 and C3dg to the CR2 complement receptor induces growth of an Epstein-Barr virus-positive human B cell line.

Authors:  A Hatzfeld; E Fischer; J P Levesque; R Perrin; J Hatzfeld; M D Kazatchkine
Journal:  J Immunol       Date:  1988-01-01       Impact factor: 5.422

6.  Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes.

Authors:  G R Nemerow; M E McNaughton; N R Cooper
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

7.  A new, sensitive assay to determine immunological adjuvant activity based on the immunogenicity of neuraminidase-treated sheep erythrocytes.

Authors:  H van Dijk; P M Rademaker; J P Klerx; C J Beukelman; J M Willers
Journal:  Methods Find Exp Clin Pharmacol       Date:  1986-03

8.  Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes.

Authors:  R H Carter; M O Spycher; Y C Ng; R Hoffman; D T Fearon
Journal:  J Immunol       Date:  1988-07-15       Impact factor: 5.422

9.  Anti-complementary amines are immunological adjuvants in mice.

Authors:  J P Klerx; J M van Oosterhout; H van Dijk; E A Kouwenberg; J M Willers
Journal:  Immunol Lett       Date:  1985       Impact factor: 3.685

10.  In vivo anti-complementary activities of the cobra venom factors from Naja naja and Naja haje.

Authors:  C W Van den Berg; P C Aerts; H Van Dijk
Journal:  J Immunol Methods       Date:  1991-02-15       Impact factor: 2.303

View more
  1 in total

Review 1.  Peanut allergy and anaphylaxis.

Authors:  Fred D Finkelman
Journal:  Curr Opin Immunol       Date:  2010-11-02       Impact factor: 7.486

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.